Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
57.68
+0.16 (+0.28%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about CVS Health Corp
< Previous
1
2
3
Next >
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation – CVS
May 15, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation - CVS
May 14, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation - CVS
May 14, 2024
WHY: NEW YORK, NY - (NewMediaWire) - May 14, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of CVS Health...
Via
TheNewswire.com
CVS INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation - CVS
May 12, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
CVS Corp. (NYSE: CVS) Making Surprising Moves in Tuesday Session
December 05, 2023
Via
Investor Brand Network
CVS INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation - CVS
May 12, 2024
WHY: NEW YORK, NY - (NewMediaWire) - May 12, 2024 - Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of CVS Health...
Via
TheNewswire.com
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation – CVS
May 10, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bounce Alert: 3 Large Caps With RSIs Too Good To Ignore
May 10, 2024
The sudden divergence has made clear some laggards who have ultra-low RSI readings that might just be too good to ignore. Here are 3 worth watching closely.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation – CVS
May 09, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
May 03, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
May 02, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of CVS Health Corporation (CVS) on Behalf of Investors
May 02, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
May 01, 2024
From
Schall Law
Via
GlobeNewswire
Humana Leaves Shareholders in Limbo on 2025 EPS Guidance
May 01, 2024
Health insurer Humana reported Q1 2024 earnings, getting a less dramatic reaction than its Q4 2023 report, causing shares to tumble more than 13%.
Via
MarketBeat
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
April 30, 2024
CVS stock is making its way above Walgreens as a potential watchlist addition. Fundamentals and price targets see the stock making a comeback this year.
Via
MarketBeat
DoorDash: 5 Compelling Reasons to Buy the Dip
April 29, 2024
DoorDash Inc. (NASDAQ: DASH) is the leading restaurant and food delivery service in the United States - should you buy the dip?
Via
MarketBeat
Topics
Death
Exposures
Death
5 High-Yielding Oversold Stocks with Bullish Ratings
April 26, 2024
Investors have favored defensive sectors in the short term, and oversold high-yielding names might become more in play as tensions rise and the market pulls in.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
The Honest Company is Undergoing an Honestly Solid Turnaround
March 19, 2024
The Honest Company stock is up 30% after the company issued a bullish outlook for 2024 revenue and earnings, particularly in the second half of the year
Via
MarketBeat
Topics
Initial Public Offering
Exposures
Securities Market
AM Best Affirms Credit Ratings of Most of CVS Health Corporation’s Aetna Inc. Subsidiaries; Withdraws Credit Ratings of Members of Texas Health Aetna
March 13, 2024
From
AM Best
Via
Business Wire
Can UnitedHealth Group afford to keep Medicare Advantage plans?
February 19, 2024
UnitedHealth Group has, to date, been unaffected by the rising costs of Medicare Advantage; investors must decide if that shoe is yet to drop
Via
MarketBeat
S&P 500 rockets to new highs as earnings beat estimates
February 09, 2024
The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders.
Via
MarketBeat
Topics
ETFs
Earnings
Stocks
Exposures
Financial
US Equities
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
January 30, 2024
Humana shares are falling after the health insurance carrier reported a bombshell when it cut its 2024 and 2025 earnings guidance
Via
MarketBeat
MarketBeat Week in Review – 1/15 - 1/19
January 20, 2024
The market continues to bounce back and forth as investors wait on news from the Federal Reserve later this month, but inflation may still be the bigger story
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Are CVS store closures prescription for better financial health?
January 17, 2024
CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Walgreens Boots Alliance: Is it time to take this Dog for a walk?
January 04, 2024
Walgreens cut its dividend in half to right-size the payment and preserve cash flow; the stock still yields about 4% and trades at a deep value.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Quick list of bargain stocks to end the year
December 15, 2023
Stocks are soaring after a FED dovish pivot, making these value stocks all the more attractive today. Analysts have built up cases as to why they will rally
Via
MarketBeat
MarketBeat Week in Review – 12/4 - 12/8
December 09, 2023
Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Is CVS stock ready for a rebound?
December 07, 2023
After consolidating from this year's selloff, for those of us on the sidelines, this is about as clear a low as you can expect to see.
Via
MarketBeat
Mega merger in the works? Humana, Cigna explore big deal
December 02, 2023
Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion.
Via
MarketBeat
Teva Pharma is the way to play the re-rise of generic drugs
November 28, 2023
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth
Via
MarketBeat
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.